IFRX
Price
$0.82
Change
-$0.02 (-2.38%)
Updated
Aug 7 closing price
Capitalization
55.22M
83 days until earnings call
LADX
Price
$0.61
Change
-$0.00 (-0.00%)
Updated
Aug 7 closing price
Capitalization
302.01K
Interact to see
Advertisement

IFRX vs LADX

Header iconIFRX vs LADX Comparison
Open Charts IFRX vs LADXBanner chart's image
InflaRx
Price$0.82
Change-$0.02 (-2.38%)
Volume$673.72K
Capitalization55.22M
LadRx
Price$0.61
Change-$0.00 (-0.00%)
Volume$14.09K
Capitalization302.01K
IFRX vs LADX Comparison Chart in %
Loading...
IFRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LADX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IFRX vs. LADX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IFRX is a Buy and LADX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (IFRX: $0.82 vs. LADX: $0.61)
Brand notoriety: IFRX and LADX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IFRX: 198% vs. LADX: 913%
Market capitalization -- IFRX: $55.22M vs. LADX: $302.01K
IFRX [@Biotechnology] is valued at $55.22M. LADX’s [@Biotechnology] market capitalization is $302.01K. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IFRX’s FA Score shows that 0 FA rating(s) are green whileLADX’s FA Score has 0 green FA rating(s).

  • IFRX’s FA Score: 0 green, 5 red.
  • LADX’s FA Score: 0 green, 5 red.
According to our system of comparison, LADX is a better buy in the long-term than IFRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IFRX’s TA Score shows that 4 TA indicator(s) are bullish while LADX’s TA Score has 3 bullish TA indicator(s).

  • IFRX’s TA Score: 4 bullish, 3 bearish.
  • LADX’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, IFRX is a better buy in the short-term than LADX.

Price Growth

IFRX (@Biotechnology) experienced а -9.93% price change this week, while LADX (@Biotechnology) price change was -41.90% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.18%. For the same industry, the average monthly price growth was +8.39%, and the average quarterly price growth was +12.02%.

Reported Earning Dates

IFRX is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+1.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IFRX($55.2M) has a higher market cap than LADX($302K). LADX YTD gains are higher at: -63.690 vs. IFRX (-67.000). LADX has higher annual earnings (EBITDA): -3.51M vs. IFRX (-44.22M). IFRX has more cash in the bank: 65.9M vs. LADX (207K). LADX has less debt than IFRX: LADX (0) vs IFRX (703K). IFRX has higher revenues than LADX: IFRX (130K) vs LADX (0).
IFRXLADXIFRX / LADX
Capitalization55.2M302K18,278%
EBITDA-44.22M-3.51M1,261%
Gain YTD-67.000-63.690105%
P/E RatioN/A1.88-
Revenue130K0-
Total Cash65.9M207K31,836%
Total Debt703K0-
FUNDAMENTALS RATINGS
IFRX vs LADX: Fundamental Ratings
IFRX
LADX
OUTLOOK RATING
1..100
5478
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
46
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
6598
P/E GROWTH RATING
1..100
10095
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LADX's Valuation (46) in the Pharmaceuticals Other industry is in the same range as IFRX (62) in the Biotechnology industry. This means that LADX’s stock grew similarly to IFRX’s over the last 12 months.

LADX's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as IFRX (100) in the Biotechnology industry. This means that LADX’s stock grew similarly to IFRX’s over the last 12 months.

IFRX's SMR Rating (97) in the Biotechnology industry is in the same range as LADX (100) in the Pharmaceuticals Other industry. This means that IFRX’s stock grew similarly to LADX’s over the last 12 months.

IFRX's Price Growth Rating (65) in the Biotechnology industry is somewhat better than the same rating for LADX (98) in the Pharmaceuticals Other industry. This means that IFRX’s stock grew somewhat faster than LADX’s over the last 12 months.

LADX's P/E Growth Rating (95) in the Pharmaceuticals Other industry is in the same range as IFRX (100) in the Biotechnology industry. This means that LADX’s stock grew similarly to IFRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IFRXLADX
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
74%
Momentum
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 8 days ago
78%
N/A
Declines
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
IFRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LADX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GENTF11.15N/A
N/A
G5 Entertainment AB
RKHNF0.04N/A
N/A
Rockhaven Resources, Ltd.
CNLPM32.76N/A
N/A
Connecticut Light & Power Co. (The)
LFABF36.00N/A
N/A
Lifco AB
THDDY19.10N/A
N/A
TV Asahi Holdings Corp.

IFRX and

Correlation & Price change

A.I.dvisor tells us that IFRX and NNVC have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IFRX and NNVC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IFRX
1D Price
Change %
IFRX100%
-2.96%
NNVC - IFRX
30%
Poorly correlated
N/A
VERA - IFRX
28%
Poorly correlated
-4.46%
ALLO - IFRX
28%
Poorly correlated
-0.94%
TENX - IFRX
26%
Poorly correlated
-2.13%
ARWR - IFRX
26%
Poorly correlated
-2.46%
More

LADX and

Correlation & Price change

A.I.dvisor tells us that LADX and TCRX have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LADX and TCRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LADX
1D Price
Change %
LADX100%
N/A
TCRX - LADX
22%
Poorly correlated
-5.71%
MREO - LADX
22%
Poorly correlated
-0.63%
NXTC - LADX
21%
Poorly correlated
-1.26%
NICXF - LADX
20%
Poorly correlated
N/A
IFRX - LADX
20%
Poorly correlated
-2.96%
More